To investigate the role of CD40L+CD8+ T cells in tumor control, we first assessed the capacity of tumor-reactive CD8+ T cells to express CD40L in an ectopic tumor model with SV40 T antigen (TAg)–expressing immunogenic cancer cells isolated from LoxPTAg mice (22, 23). The gene discussed is CD8A; the disease is cancer.